Cervical cancer is the second most common cancer in the world and the leading cause of death. Frequency and mortality are significantly reduced thanks to cytological Papanicolau test (PAP). Regular PAP test can reduce approximately 80 % of cases of this cancer. Aim of the study: to examine frequency of cervical cancer and changes of cervix, the age of risk for the changes and effect of frequency of PAP test. Materials and methods: 3383 PAP (cytological) findings have been retrospectively ana lysed in three Health Centres of Tuzla Canton: Tuzla, Srebrenik and Sapna. During 2010 and 2011 protocols of Health Centers have been analyzed. Results: Analysis of 3383 smears detected the following: abnormal PAP tests i
Background: Pap tests can detect changes inside the cells of the cervix before cancer develops. O...
Introduction: Pap smear is a simple, convenient, cost effective and reliable test for early screenin...
In developing countries cervical cancer is a leading cause of death in females. In more than 90% of...
Objectives: The Papanicolaou cervical cytology test is capable of detecting cervical cancer at an ea...
Mortality due to cervical cancer can be reduced by early detection of the premalignant lesion of cer...
ObjectiveCervical cancer (CC) screening by Pap smears has led to a decrease in the incidence of CC w...
Background: Cancer cervix is fourth most common cancer in world and second most common in India. It ...
Objective: At the present time, cervical cancer remains the fourth most prevalent cancer among women...
Cervical cancer is the most common cancer. Pap smear testing can detect cervix precursor lesions ear...
Since the development of cytology-based cervical cancer screening using PAP test in the mid-20th cen...
Objectives To report changes in incidence of cervical tumours by disease stage, following the introd...
Objectives: To determine the prevalence of abnormal Papanicolaou (Pap) smears in patients visiting t...
Cervical cancer is a health issue that disproportionately affects developing countries, where the Pa...
A B S T R A C T We analyzed the influence of cytology development to frequency of precancerosa (Cerv...
Background: Cervical cancer is one of the most common cancers of Indian females. Western Rajasthan d...
Background: Pap tests can detect changes inside the cells of the cervix before cancer develops. O...
Introduction: Pap smear is a simple, convenient, cost effective and reliable test for early screenin...
In developing countries cervical cancer is a leading cause of death in females. In more than 90% of...
Objectives: The Papanicolaou cervical cytology test is capable of detecting cervical cancer at an ea...
Mortality due to cervical cancer can be reduced by early detection of the premalignant lesion of cer...
ObjectiveCervical cancer (CC) screening by Pap smears has led to a decrease in the incidence of CC w...
Background: Cancer cervix is fourth most common cancer in world and second most common in India. It ...
Objective: At the present time, cervical cancer remains the fourth most prevalent cancer among women...
Cervical cancer is the most common cancer. Pap smear testing can detect cervix precursor lesions ear...
Since the development of cytology-based cervical cancer screening using PAP test in the mid-20th cen...
Objectives To report changes in incidence of cervical tumours by disease stage, following the introd...
Objectives: To determine the prevalence of abnormal Papanicolaou (Pap) smears in patients visiting t...
Cervical cancer is a health issue that disproportionately affects developing countries, where the Pa...
A B S T R A C T We analyzed the influence of cytology development to frequency of precancerosa (Cerv...
Background: Cervical cancer is one of the most common cancers of Indian females. Western Rajasthan d...
Background: Pap tests can detect changes inside the cells of the cervix before cancer develops. O...
Introduction: Pap smear is a simple, convenient, cost effective and reliable test for early screenin...
In developing countries cervical cancer is a leading cause of death in females. In more than 90% of...